Dallas Hack
Directeur Général chez VirTech Bio, Inc.
Fortune : 14 $ au 31/05/2024
Profil
Dallas C.
Hack is currently the Chief Executive Officer & Director at VirTech Bio, Inc. He is also a Director at SteriLumen, Inc. and Hemispherian AS.
Previously, he served as an Independent Director at Applied UV, Inc. from 2020 to 2024.
He was also an Associate Professor at Virginia Commonwealth University and a Member of the Order of Military Medical Merit.
Dr. Hack holds an undergraduate degree from Andrews University, a graduate degree from The Johns Hopkins University, a doctorate degree from Loma Linda University, and a graduate degree from the U.S.
Army War College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
APPLIED UV, INC.
0,01% | 16/04/2024 | 360 ( 0,01% ) | 14 $ | 31/05/2024 |
Postes actifs de Dallas Hack
| Sociétés | Poste | Début |
|---|---|---|
SteriLumen, Inc.
 SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Directeur/Membre du Conseil | - |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Directeur/Membre du Conseil | - |
VirTech Bio, Inc.
 VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Directeur Général | 17/03/2022 |
Anciens postes connus de Dallas Hack
| Sociétés | Poste | Fin |
|---|---|---|
| APPLIED UV, INC. | Directeur/Membre du Conseil | 06/05/2024 |
| Virginia Commonwealth University | Corporate Officer/Principal | 01/01/2015 |
| Order of Military Medical Merit | Corporate Officer/Principal | - |
Formation de Dallas Hack
| Andrews University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Loma Linda University | Doctorate Degree |
| U.S. Army War College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APPLIED UV, INC. | Process Industries |
| Entreprise privées | 4 |
|---|---|
SteriLumen, Inc.
SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Producer Manufacturing |
VirTech Bio, Inc.
VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Health Technology |
| Order of Military Medical Merit | |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
